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Streptococcus Induces Circulating CLAþ Memory
T-Cell-Dependent Epidermal Cell Activation in
Psoriasis
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Ana Gime´nez-Arnau1, Antonio Celada2, Ramon M. Pujol1 and Luis F. Santamaria-Babı´1,2
Streptococcal throat infection is associated with a specific variant of psoriasis and with HLA-Cw6 expression.
In this study, activation of circulating psoriatic cutaneous lymphocyte–associated antigen (CLA)þ memory
T cells cultured together with epidermal cells occurred only when streptococcal throat extracts were added.
This triggered the production of Th1, Th17, and Th22 cytokines, as well as epidermal cell mediators
(CXCL8, CXCL9, CXCL10, and CXCL11). Streptococcal extracts (SEs) did not induce any activation with either
CLA cells or memory T cells cultured together with epidermal cells from healthy subjects. Intradermal injection
of activated culture supernatants into mouse skin induced epidermal hyperplasia. SEs also induced activation
when we used epidermal cells from nonlesional skin of psoriatic patients with CLAþ memory T cells. Significant
correlations were found between SE induced upregulation of mRNA expression for ifn-g, il-17, il-22, ip-10,
and serum level of antistreptolysin O in psoriatic patients. This study demonstrates the direct involvement
of streptococcal infection in pathological mechanisms of psoriasis, such as IL-17 production and epidermal
cell activation.
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INTRODUCTION
In recent years, the characterization of the molecular mechan-
isms of psoriasis has greatly improved and has revealed new
therapeutic targets. However, many questions remain regard-
ing how psoriatic lesions are triggered and initiated (Nestle
et al., 2009). A correlation between streptococcal infection and
psoriasis has been identified using clinical and epidemiological
data (Valdimarsson et al., 2009; Leung et al., 1995; Baker
et al., 2006; Thorleifsdottir et al., 2012). In the blood of
psoriatic patients, T cells that recognize determinants common
to streptococcal M-proteins and keratins (Gudjonsson et al.,
2003) and other possible autoantigens have been identified
(Besgen et al., 2010). Circulating cutaneous lymphocyte–
associated antigen (CLA)þCD8þ T cells respond with IFN-g
production to keratin peptides that share sequence with
M-proteins (Johnston et al., 2004) in HLA-Cw*0602(þ )
psoriasis patients, and skin-derived CD4þ T cells produce
IFN-g in response to streptococcal antigen (Brown et al., 2000).
In addition, streptococcal DNA induces activation and
proliferation of CLAþ T cells in psoriasis (Cai et al., 2009).
Although the relevance of streptococcal throat infection is
known for 450 years (Norrlind, 1955), no functional evidence
has linked Streptococcus with the induction of Th17/Th22
cytokines and epidermal activation/hyperplasia, hallmarks of
psoriatic lesion (Nestle et al., 2009).
Circulating CLAþ T cells, a subset of memory T cells with
skin tropism, preferentially respond to antigens/allergens
involved in cutaneous diseases mediated by T cells
(Santamaria Babi et al., 1995a). These CLAþ T cells
represent a subset of memory/effector T lymphocytes
associated with the cutaneous immune system (Santamaria-
Babi, 2004). CLAþ T cells have been analyzed in psoriasis,
suggesting an early migration of those cells into the skin before
the plaque lesion is established (Davison et al., 2001; Vissers
et al., 2004), as well as their participation in the acute stages
of psoriasis, psoriatic score, and affected body surface area
(Sigmundsdottir et al., 2001; Pont-Giralt et al., 2006; Ferran
et al., 2008). The recruitment of circulating CLAþ T cells into
the skin is considered one of the relevant features in the
pathogenesis of psoriasis (Guttman-Yassky et al., 2011;
Laggner et al., 2011). Chronic streptococcal stimulation in
the tonsils provides a source of pathogenic CLAþ T cells
(Sigmundsdottir et al., 2003) that could home into skin and
participate together with innate immune mechanisms in the
ORIGINAL ARTICLE
1Department of Dermatology, Hospital del Mar, Research Group in
Inflammatory Dermatologic Diseases, IMIM, Universitat Auto`noma de
Barcelona, Barcelona, Spain and 2Institute for Research in Biomedicine (IRB
Barcelona), and Departament of Fisiologia I Immunologia, Universitat de
Barcelona, Barcelona, Spain
Correspondence: Luis F. Santamaria-Babı´, Institute for Research in
Biomedicine (IRB Barcelona), Baldiri Reixac, 10, Barcelona 08028, Spain.
E-mail: luis.santamaria@ub.edu
Received 4 November 2011; revised 7 August 2012; accepted 8 August
2012; published online 29 November 2012
Abbreviations: ASO, antistreptolysin O; CLA, cutaneous lymphocyte–
associated antigen; SE, streptococcal extract; SEB, superantigen enterotoxin B
& 2013 The Society for Investigative Dermatology www.jidonline.org 999
initiation of psoriatic lesions (Nestle et al., 2009; Guttman-
Yassky et al., 2011). The goal of this study has been to
determine the direct involvement of Streptococcus in psoriasis
through its interaction with circulating CLAþ memory T cells
and epidermal cells, two relevant cell populations involved in
the pathogenesis of the disease.
RESULTS
Streptococcal extract (SE) induces upregulation of mRNA
expression for ifn-c, il-17, il-22, and ip-10 in circulating psoriatic
CLAþ T cells cultured with lesional autologous epidermal cells
Infiltrating CLAþ memory T cells and epidermal cells are in
close contact in psoriatic lesions (Robert and Kupper, 1999).
We attempted to mimic this situation by in vitro culturing
circulating CLAþ memory T cells and autologous epidermal
cells from psoriatic patients. Neither T cells nor epidermal
cells were stimulated. However, after the addition of SE to the
culture, a time-dependent upregulation in mRNA expression
of ifn-g, il-17, il-22, and ip-10 was observed (Figure 1a). This
activation seems to be specific and restricted to the subset of
skin-homing memory T cells because it occurs with CLAþ but
not with CLA T cells. Moreover, circulating CLAþ or CLA
memory T cells and autologous epidermal cells from controls
after SE activation showed a minimal increase in the tran-
scription of these genes (Figure 1b).
SE induces IFN-c and IL-17 production in CLAþ T cells cultured
with autologous lesional epidermal psoriatic cells
The increase in mRNA expression correlates with cytokine
production (IFN-g and IL-17), as measured in the supernatants
after 48 hours of culture (Figure 2a and b). In four of the five
patients tested, a marked increase of cytokines was observed
because of the presence of SE. No such increase was
produced when CLA T cells were used or the experiment
was conducted with skin from healthy donors. When we used
a nonspecific stimulus, such as superantigen enterotoxin B
(SEB), IL-17 and IFN-g were produced in both CLAþ and
CLA subsets from control subjects, indicating lack of
response to SE, but not to SEB (Figure 2c and d). To further
characterize mediators induced by the activation produced of
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Figure 1. Streptococcal extract (SE) induces upregulation of mRNA for ifn-c, il-17, il-22, and ip-10 in psoriatic cutaneous lymphocyte–associated antigen
(CLA)þ T cells cultured with lesional autologous epidermal cells. Culture of freshly isolated circulating CLAþ /CLA CD45ROþCD3þ cells with autologous
epidermal cells obtained from lesional psoriatic skin was incubated with or without SE. A time-course analysis of ifn-g, il-17, il-22, and ip-10 mRNA expression
was performed. RNA was taken at the indicated times after activation and determined by real-time PCR. (a) Data presented are from three psoriatic patients and (b)
from three controls.
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SE in the culture of CLAþ memory T cells and epidermal cells
from psoriatic patients, we performed a quantitative antibody
array for 13 cytokines (Figure 2e) using 5-day supernatants
taken from three representative psoriatic patients who
responded to SE. Cytokines produced by T cells and epidermal
psoriatic cells, such as IFN-g, IL-17 and IL-21, IL-12p40, IL-
12p70, IL-6, CXCL11, CXCL10, CXCL9, and CXCL8, were
significantly increased by SE in the cultures of CLAþ T cells
and epidermal cells in relation to CLA . As expected, the
activation induced by SE produced a strong proliferation in the
cultures of CLAþ T cells with lesional epidermal cells
(Supplementary Figure S2 online). Therefore, the SE induced
an exacerbated immune response in our in vitro system. The
SE response was restricted to the CLAþCD45ROþ T cells;
however, Candida Albicans and SEB responses were not
restricted to the skin-homing T-cell subset in pooled results
from 5-day supernatants generated from four different patients
(p24, p25, p26, and p27), as shown in Supplementary Figure
S3 online. The dotted lines indicate the amount of cytokine
production obtained by SE activation in the CLA T-cell
subset for each mediator.
Supernatants of SE-activated CLAþ T cells and epidermal cells
generate epidermal hyperplasia in vivo
Up to this point, we have found a significant increase in
cytokines in the supernatants of the cultures. To assess the
relevance of these ex vivo cultures on an in vivo model, we
injected the supernatants intradermally in Balb/c mice. A
significant epidermal hyperplasia, characteristic of psoriatic
skin, was found when we injected supernatants of cultures of
CLAþ T cells incubated with lesional epidermal cells from
psoriatic skin activated with SE (Figure 3a–c). However, the
cultures containing CLA of the same patient induced a
minor epidermal thickness (Po0.001).
SE-induced upregulation of mRNA expression for ifn-c, il-17,
il-22, ip-10, tnf-a, and il-8 in cultures of CLAþ /CLA T cells
of nonlesional epidermal cells of psoriasis patients
CLAþ T cells are present in the nonlesional marginal edge of
psoriatic lesions before epidermal hyperplasia occurs (Davison
et al., 2001; Vissers et al., 2004), and are considered to be
relevant elements in the early events of plaque psoriasis
formation (Guttman-Yassky et al., 2011) together with other
cell types, such as plasmocytoid dendritic cells (Albanesi
et al., 2009), thereby suggesting an initial involvement of
skin-homing T cells in psoriatic lesion development. We
assessed whether SE induces psoriatic gene expression in
cultures of nonlesional epidermal cells and autologous
circulating CLAþ T cells of psoriatic patients. The
expression of mRNA for ifn-g, il-17, il-22, tnf-a, and il-8 was
increased when nonlesional epidermal cells were cultured
with CLAþ T cells and SE (Figure 4), whereas those genes
were not detected in cells from healthy donors (data not
shown). Our results demonstrate that SE and CLAþ T cells can
induce upregulation of mRNA for some genes characteristic of
the psoriatic lesion in epidermal cells obtained from non-
lesional psoriatic skin.
Correlation between serum antistreptolysin O (ASO) antibody
levels and SE-induced upregulation of mRNA of ifn-c, il-17, il-22,
and ip-10 in CLAþ T cells cultured together with epidermal cells
in psoriatic patients
As SE is able to induce CLAþ T cell and epidermal cell
activation in psoriasis, we explored whether this in vitro
activity could be related to in vivo exposure to streptococcal
infection in some patients. We compared anti-ASO antibody
serum levels with the expression of ifn-g, il-17, il-22, and ip-10
obtained in the culture of circulating CLAþ memory T cells
and epidermal cells 24 hours after activation by SE. As shown
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Figure 2. Streptococcal extract (SE) induces IFN-c and IL-17 production in cutaneous lymphocyte–associated antigen (CLA)þ T cells cultured with autologous
lesional epidermal psoriatic cells. Supernatants from cultured memory T cells (CLAþ /CLA ) and autologous lesional epidermal psoriatic cells stimulated with
SE or with Staphylococcus aureus enterotoxin B (SEB) for controls were analyzed for IFN-g and IL-17 after 48 hours of culture by ELISA. (a–d) Data are presented
from five psoriatic patients (p) and three controls (c) as net cytokine production.
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in Figure 5, significant correlation was found between anti-
ASO levels and the expression of ifn-g (r¼ 0.77, P¼0.01), il-17
(r¼0.89, P¼ 0.001), il-22 (r¼ 0.91, P¼0.0005), and ip-10
(r¼0.86, P¼0.002). In addition, those ASO values also
correlated with psoriasis area severity index scores (r¼0.68,
P¼0.04), with a lower score in guttate patients (data not
shown). The mRNA for those same genes was not amplified in
cultures of CLA memory T cells and epidermal cells
activated by SE from the same patients.
Influence of major histocompatibility complex class I or class II
on SE-activated cultures of memory T cells with epidermal cells
Our cultures are established using CD3þCD45R0þ cells.
Therefore, we attempted to characterize the involvement of
HLA class I or class II in the activation of cultures of CLAþ
memory T cells and epidermal cells using blocking antibodies
(Figure 6 and Supplementary Figure S4C online). We simulta-
neously quantified IFN-g, IL-17A, IL-6, and TNF-a in 5-day
supernatants by flow cytometry. The SE-dependent activation
of the culture of CLAþ T cells and epidermal cells depends on
the HLA class I and HLA class II molecules, because blocking
antibodies reduces cytokine production; anti-HLA class II is
significantly more active than anti-HLA class I: IL-17A
(Po0.0001), IFN-g (Po0.03), and TNF-a (Po0.001). As
expected, the generation of new epidermal cells was also
impaired. The generation of a new population of epidermal
cells that appears only in the culture condition of CLAþ
memory T cell and epidermal cells activated by SE (Figure 4a),
with reduced staining to CFSE compared with the whole
population of epidermal cells after 4 days in culture
(Figure 4b), and contains CD29þHLA-DRþ cells, was
reduced by the effect of blocking antibodies (Figure 4c).
DISCUSSION
T cells are considered to represent a functional link between
streptococcal tonsillitis and psoriatic inflammation (Diluvio
et al., 2006; Besgen et al., 2010). Although clinical association
between streptococcal infections and psoriasis are well
established (Valdimarsson et al., 2009), the inflammatory
mechanisms involved are poorly characterized. A direct
proof of the capacity of SE to induce hallmarks of psoriasis
response, such as Th17 response, epidermal activation, and
hyperplasia, in vivo selectively through circulating CLAþ T
cells in psoriasis would support this hypothesis (Valdimarsson
et al., 2009). To test this concept, we developed an ex vivo
culture system where circulating memory CLAþ /CLA T cells
are cultured together with autologous lesional or nonlesional
epidermal cells with/o SE in cells from patients with psoriasis
or healthy controls. The SE we use is a mixture of four heat-
killed and sonicated streptococcal throat isolates from patients
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Figure 3. Supernatants of streptococcal extract (SE)–activated cutaneous lymphocyte–associated antigen (CLA)þ T cells and epidermal cells generate epidermal
hyperplasia in vivo. Intradermal injection of supernatants from CLAþ T cells cultured with lesional epidermal cells activated with SE induces in vivo epidermal
hyperplasia in Balb/c mice. Supernatant from day 6 of the culture was injected intradermally in Balb/c mice daily for 4 days, and epidermal hyperplasia was
evaluated at day 4. (a–c) Results are shown with histological images of skin biopsies (hematoxylin and eosin) and a comparative graphic of epidermis thickness (in
micrometers) after supernatant injections in four mice (Po0.001). Bar¼50mm.
Patient 9
IFN-γ
IL-17
IL-22
IP-10
TNF-α
IL-8
1 10 100 1,000 10,000
Patient 10
IFN-γ
IL-17
IL-22
IP-10
TNF-α
IL-8
1 10 100 1,000 10,000 100,000
Relative units
CLA+CD45RO+CD3+ CLA−CD45RO+CD3+
Figure 4. Streptococcal extract–induced upregulation of mRNA for ifn-c,
il-17, il-22, ip-10, tnf-a, and il-8 in cultures of cutaneous lymphocyte–
associated antigen (CLA)þ /CLA T cells of nonlesional epidermal cells of
psoriasis patients. Upregulated gene transcription in the culture 24 hours after
activation. Data are presented for two patients with nonlesional epidermal
cells.
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with psoriasis. Such preparation has been shown to induce
CLA expression by T cells (Baker et al., 1997).
The cytokines IFN-g, IL-17, IL-21, and IL-22 are well-known
inducers of epidermal activation and hyperplasia in psoriasis
(Guttman-Yassky et al., 2011). It is interesting to see that SE
can trigger the expression of all those four mediators in
psoriasis when circulating CLAþ T cells and epidermal cells
are cultured together. The difference found in the amount of
IFN-g, IL-17, and IL-21 compared to IL-22 in the antibody
array deserves further exploration. Difference in the frequency
of those T-cell subsets in the blood of psoriatic patients, and
also the timing of supernatant collection in our model, might
explain the lower levels of IL-22 found after 5 days. IL-21 is a
cytokine recently associated with psoriasis (Caruso et al.,
2009) that is produced by circulating and infiltrating CLAþ
T cells in psoriasis and also induces epidermal hyperplasia.
Cells producing IL-17, IL-21 of IL-22 are rarely found in
circulating T lymphocytes (Eyerich et al., 2009). However, the
amount of IFN-g, IL-17, and IL-21 obtained with our ex vivo
culture, using only 5104 circulating CLAþ T cells and
3104 epidermal cells activated by SE after 5 days of culture,
are in the same range to the amount obtained using cloned
1106 T cells polyclonally activated for 48 hours (Eyerich
et al., 2009). These results suggest that, in psoriasis, there is an
enrichment of IFN-g, IL-17, IL-21, and IL-22 producing T cells
responding to SE within the subset of circulating CLAþ T-cell
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Figure 5. Streptococcal extract–induced upregulation in gene transcription for ifn-c, il-17, il-22, and ip-10 after 24 hours of activation of cutaneous lymphocyte–
associated antigen (CLA)þ memory T cells and epidermal cells correlates with antistreptolysin O (ASO) serum levels in psoriatic patients. Patients are identified
by number and psoriasis type (C, chronic; G, guttate).
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subset in psoriasis. This observation is in line with the general
functional involvement of circulating CLAþ T cells in other
skin diseases (Santamaria-Babi, 2004). In contrast to the
epidermal cells from controls, nonlesional epidermal cells
could be activated with autologous CLAþ T cells and SE
inducing the expression of Th1 and Th17 cytokines, as well as
epidermal cell mediators, such as IP-10 (Gottlieb et al., 1988)
and IL-8 (Sticherling et al., 1991). These results are in
accordance with the model in which SE activated specific
circulating CLAþ T cells that, upon migration to the skin,
could participate in lesion induction (Valdimarsson et al.,
2009).
We did not observe IL-23 production in our cultures. This is
not surprising because dermal dendritic cells are the main
producers of IL-23 in psoriasis (Tonel et al., 2010), and our
cultures were devoid of dermal cells. It has been shown that
keratinocytes can produce IL-12p40 and IL-12p70 (Aragane
et al., 1994). Interestingly, we observed that IL-12p40 and IL-
12p70 are produced in the supernatants of activated epithelial
cells, which concur with previous results in psoriatic lesions
(Lee et al., 2004). We also detected the production of the
chemokines CXCL11, CXCL10, CXCL9, and CXCL8
(Figure 2e). These chemokines are expressed in psoriatic
lesions (Nograles et al., 2008) and are potent
chemoattractants of immune cells found in the lesions.
Although the epidermal cell suspension from psoriasis
lesions contained immune cells, we do not attribute our
results to those cells. The same epidermal cell suspension is
added to either circulating CLAþ or CLA memory T cells. If
SEs were interacting with epidermal immune cells, the culture
of CLA memory T cells with SE and epidermal cells should
also be activated. This is not the case. In addition, it is clear
that the epidermal cell activation (CXCL11, CXCL10, CXCL9,
and CXCL8) in our system depends on the presence of
circulating CLAþ memory T cells but not CLA .
Our results indicate that SEs trigger the activation of key
psoriatic T-cell cytokines and epidermal chemokines through
the interaction of CLAþ T cells with either lesional or
nonlesional skin of psoriatic patients. The correlation between
in vivo and in vitro findings was confirmed by the develop-
ment of epidermal hyperplasia after injection of supernatants
of SE-activated CLAþ T cells and epidermal cells from
psoriatic patients in the mouse skin. Interestingly, in our
culture, we identified an epidermal cell population that
present decreased staining to CFSE, suggesting a proliferative
state, and express HLA-DR/CD29 that only appears upon the
activation of SE and in the condition with CLAþ memory T
cells and epidermal cells. This population decreases when
blocking antibodies to major histocompatibility complex
class I or class II are used. Although our culture system is
not optimal for keratinocyte proliferation, our data suggest that
it may be useful to study early activation of epidermal cells
and T cells by SE. In addition, the production of IL-17A, IFN-g,
IL-6, and TNF-a in 5-day supernatants of cultures of CLAþ T
cells and epidermal cells activated with SE could also be
inhibited by blocking antibodies against HLA class I and HLA
class II, having stronger activity anti-HLA class II. One possible
hypothesis for the activity of both blocking antibodies would
be that SE antigens could be presented to CD4þ , and
cytokines derived from CD4þ T cells could induce autoanti-
gens on epidermal cells (Shi et al., 2011) that later can be
recognized by CD8þ T cells in HLA class I context. For this
reason blockage of major histocompatibility complex class II
could have stronger effect because it inhibits early
mechanisms in our culture system.
In a high percentage of guttate psoriasis patients, strepto-
coccal tonsillitis leads to relapses of psoriasis (Norrlind, 1955;
Gudjonsson et al., 2003; Mallbris et al., 2005). For some of the
patients in our cohort, serum levels of ASO were recorded at
the moment of blood and biopsy extraction. We have found a
significant correlation between ASO and SE-induced
upregulation of mRNA expression at 24 hours for ifn-g, il-17,
il-22, and ip-10 only in the culture of CLAþ memory T cells
and epidermal cells. Although this is a limited number of
patients, the results suggest that SE induces higher activation of
CLAþ T cells and epidermal cells in the patients presenting
higher ASO levels.
The HLA-Cw*0602 data of our patients suggest that strep-
tococcal-induced activation of CLAþ memory T cells and
epidermal cells is not restricted to HLA-Cw*0602-positive
patients. This concurs with early results, indicating that not all
patients with streptococcal-related psoriasis carry HLA-
CW*0602 (Fry et al., 2006). Our current results do not
establish any differences between guttate and chronic
plaque psoriasis. However, patients 15 and 13 have guttate
psoriasis with high ASO, onset associated with pharyngeal
streptococcal infection, and higher upregulation of mRNA for
ifn-g, il-17, il-22, and ip-10 in CLAþ T cells and epidermal
cells (Figure 5). We would hypothesize that this type of patient
may present the highest activation response to SE, in line with
published data that indicate that HLA-Cw*0602-positive
psoriasis patients have a more severe disease (Gudjonsson
et al., 2006).
Our separation methods obtain CLAþ /CLA memory T
cells that can be either a/b or g/d. Circulating CLAþ Vg9Vd2 T
cells can migrate from blood to skin, their number correlate
with the clinical course of psoriasis and produce IL-17
(Laggner et al., 2011). In addition, gd-T cells are greatly
increased in lesional psoriatic lesion and produce large
amounts of IL-17 (Cai et al., 2011). It could be hypothesized
that our purified CLAþ T-cell subsets contain some gd-T cells
that could react to some antigens present in the SE. In fact,
streptococcal antigens can be recognized and activate gd-T
cells (Bender et al., 1993; Bender and Kabelitz, 1992;
Grinlinton et al., 1993). We are currently exploring this
interesting possibility.
To date, a direct effect of SE on circulating CLAþ T cells
that can explain how this induces new lesions in psoriatic
patients has not been demonstrated. Our results from these
culture experiments with psoriatic cells provide experimental
evidence that Streptococcus is a relevant trigger of psoriasis
lesions through its interaction with circulating skin-homing T
cells and epidermal cells. The ex vivo culture model used in
this study will contribute to clarifying the molecular mechan-
ism involved in the proposed molecular mimicry of the
autoimmune origin of psoriasis (Valdimarsson et al., 2009;
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Besgen et al., 2010), and can be a valuable model to try new
experimental therapies.
MATERIALS AND METHODS
Patients
The study included 27 psoriatic patients (15 with guttate psoriasis, 9
with chronic plaque psoriasis and 3 with acute plaque psoriasis) and
6 healthy controls. Detailed patients’ characteristics can be found in
Supplementary Table SI online. Patients and healthy controls partici-
pated voluntarily and gave written informed consent. Patients with
erythrodermic pustular psoriasis or arthritis were excluded. We
assessed psoriasis area severity index scores, disease extent (body
surface area affected), and clinical characteristics. All the participants
underwent a skin biopsy and a blood extraction. The samples were
collected after a minimum period of 6 weeks without treatment of any
kind. The study was approved by the Medical Ethics Committee of
Hospital del mar, and written consent was obtained from all
participants; this work was conducted according to the Declaration
of Helsinki principles.
Purification of circulating peripheral blood CLAþ /CLA
memory T cells
Circulating CLAþ or CLACD45R0þ CD3þ cells were purified from
peripheral blood mononuclear cells obtained by Ficoll separation
using 60 ml of blood. Three consecutive immunomagnetic separa-
tions were then carried out using antibodies and magnetic particle–
conjugated antibodies from Miltenyi Biotec (Bergisch Gladbach,
Germany) by a modified procedure originally described in
Santamaria Babi et al., 1995b. In the first separation, CD14þ and
CD19þ were depleted, in the second separation, CD16þ and
CD45RAþ lymphocytes were removed. Finally, in the third
separation, CD45R0þ memory T cells were divided into CLAþ and
CLA– memory T-cell subpopulations by using the Anti-CLA
MicroBead Kit (Miltenyi Biotec, Bergisch Gladbach, Germany).
After the separation by two consecutive column separations to
obtain high depletion and enrichment, the sample purity was
routinely tested for the CLA-enriched T-cell preparations containing
X95% of CLAþ cells and for the CLA-depleted preparations with
o10% CLAþ as assessed by FACS (Supplementary Figure S1 online).
Punch biopsies and epidermal cell suspension
Epidermal cells from cutaneous biopsies were isolated by incubating
skin biopsy in dispase 371C for 2hours to peel off the epidermis from the
dermis. The epidermal sheet was cut into small pieces and incubated
with trypsin for 30minutes to obtain epidermal cell suspensions.
Culture of epidermal cells together with CLAþ / memory
T cells and stimulation with different antigens
The culture system was performed by seeding 50,000 circulating
CLAþ /CLA memory T cells with 30,000 autologous epidermal cells
in a 96-flat bottom microwell plate (Nunc, Roskilde, Denmark) with
culture medium (RPMI 10% fetal calf serum) for 12, 24, 48 hours, 5,
and 6 days. SE isolated from bacteria from the throat of psoriatic
patients (1mg ml 1 final), which was kindly provided by Drs Johann
Gudjonsson and Helki Valdimarsson, C. albicans at 40mg ml 1
(Greerlabs, Lenoir, NC), SEB at 100 ng ml 1 (Sigma-Aldrich, St Louis,
MO), or equivalent culture medium, was added in both conditions
(CLAþ /CLA ) to compare all the conditions. NaN3 free blocking
antibodies for HLA class I (clone W6/32) and class II (clone L243), as
well as isotype control, were purchased from Biolegend (San Diego,
CA) and used at 10mg ml 1.
Gene expression
The RNA of cell-cultured pellets was extracted using the Trizol
(Invitrogen, Paisley, UK) and cDNA prepared using the High Capacity
cDNA Reverse Transcription kit (Applied Biosystems, Carlsbad, CA),
following the respective manufacturer’s instructions. Subsequent
analysis by real-time–PCR was performed with AB17900HT (Applied
Biosystems) and the data were processed by SDS version 1.0 analysis
program (Applied Biosystems). Primers and probes were purchased
from Applied Biosystems. The reactions were run on an Applied
Biosystems 7900HT system. Gene expression was calculated using
the DDCt method (using the mean cycle threshold value for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the
gene of interest for each sample). The equation 1.8 e(CtGAPDH
Ctgene of interest) 104 was used to obtain the normalized values
(Chan et al., 2006). Increased values were calculated by subtracting
normalized gene expression values in the culture for basal and
SE-stimulated conditions.
Cytokine determination
Supernatants were taken after 48 hours of culture, and IFN-g and IL-
17 were measured by ELISA (Peprotech, London, UK). Data are
presented from five psoriatic patients and three controls as net
cytokine production. Customized arrays of antibodies (Tebu-bio, Le
Perray en Yvelines, France) were used to simultaneously quantify the
presence in cell culture of the following human mediators: IFN-g, IL-
17, IL-21, IL-22, IL-12p40, IL-12p70, IL-23, IL-6, TNF-a, CXCL11,
CXCL10, CXCL9, and CXCL8. Supernatants were taken after 5 days of
culture. Data are presented from three psoriatic patients as net
cytokine production. Quantification of IFN-g, IL-17A, IL-6, and
TNF-a by flow cytometry was performed with a multiplex fluorescent
bead-based immunoassay, Diaclone DIAplex kit (Gen-Probe,
Besanc¸on, France), to simultaneous quantify in the 4-day super-
natants of all the culture conditions with a F500 Flow Cytometer
(Beckman Coulter, Fullerton, CA), data are presented as net cytokine
production.
Determination of ASO levels in serum
The same day that biopsies and blood were obtained, serum levels of
ASO were analyzed by an immunoturbidimetric method.
Intradermal injection of supernatants into mouse skin
Fifty-ml supernatants (1/3 diluted) collected from cultures of four
psoriatic patients on day 6 after SE activation, were intradermally
injected into the back of anesthetized Balb/c mice (daily during 4
days). Epidermal hyperplasia was evaluated at day 4. Mouse skin was
biopsied and sections from paraffin-embedded skin were prepared
and stained with hematoxylin and eosin. Animal use was approved
by the Animal Research Committee of the University of Barcelona
(number 2523).
Data analysis
Data were analyzed with the Student’s t-test. The analysis of variance
test was used to assess the statistical significance in the regression
analysis.
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